How to Maintain Pharma Supply Chain Reliance, Overall Quality, & Compliance Sustainability
Frances M. Zipp
Carmelo Rosa, PsyD
The global pandemic is impacting supply chains worldwide, but pharmaceutical supply chains are especially vulnerable. Manufacturers are under pressure to help maintain the supply of critical medicines during COVID-19 as well as contribute to the on-going efforts to support the ever-changing supply chain.
As pharmaceutical manufacturers reprioritize production due to changing and increased product demand, many don’t have alternate suppliers for critical components. This has been a game-changer as they not only have to identify new suppliers, but they must also qualify these components to ensure they understand impact on process, and that quality meets the required standards.
Manufacturing partners across geographic regions are navigating this “new normal” under stressful conditions exacerbated by increased demand for APIs, new supply chain challenges, and an ever-increasing global focus on maintaining quality. To truly succeed as an industry, we must knowledge share and problem-solve together to advance and proactively prepare for the continued success of our mission as an industry.
Nowhere else can you participate in actionable, interactive discussions featuring case studies and dedicated Q&A time with experts representing FDA, MHRA, local health authorities, Pfizer, Biocon, and more as they answer questions like:
How are others combating drug shortage challenges during the pandemic?
How do you manage multiple manufacturing sites operating at different levels of quality systems maturity?
How do you respond to a cybersecurity breach that affects your company’s entire network?
You can submit your questions on the event homepage prior to the conference or ask your questions in real-time. Stay knowledgeable throughout the year with on demand access to all session recordings and presentations for one year.
Collaboration is a crucial element in mitigating the impact of COVID-19 on the pharmaceutical supply chain. We encourage you to register today to ensure you have the strategies to make your operations more agile, compliant, and resilient to disruption.
2020 ISPE Europe Annual Conference This article covers a regulatory panel discussion at the virtual 2020 ISPE Annual Meeting & Expo on the topic of Distant Assessments on GMP and Inspection Reliance. Driven by digitalization, these assessments help the industry and regulators manage inspection...
We are constantly being influenced and we ourselves are influencers. As children, we hear the quote that “sticks and stones may break my bones, but words will never hurt me.” What people say and even what people do not say, can have a lasting impact. We are first influenced by our families and some...
2020 ISPE Europe Annual Conference At the 2020 ISPE Europe Annual Conference on 16–17 September, which was a virtual conference, three regulatory panel discussions included more than 20 regulators from eight countries and the European Medicines Agency (EMA), Medicines and Healthcare Products...